Propanc Biopharma (NASDAQ Uplisting) (PPCB) to Raise $5 Million in IPO
Propanc Biopharma (NASDAQ Uplisting) (PPCB) is planning to raise $5 million in an initial public offering (IPO) on the week of June 23rd, IPO Scoop reports. The company will issue 1,000,000 shares at $4.00-$6.00 per share. Propanc Biopharma (NASDAQ Uplisting) has a market cap of $65.6 million. D. Boral Capital (ex-EF Hutton) and Craft Capital […]
Propanc Biopharma (NASDAQ Uplisting) (PPCB) is planning to raise $5 million in an initial public offering (IPO) on the week of June 23rd, IPO Scoop reports. The company will issue 1,000,000 shares at $4.00-$6.00 per share. Propanc Biopharma (NASDAQ Uplisting) has a market cap of $65.6 million. D. Boral Capital (ex-EF Hutton) and Craft Capital […]
